Abiopharma

🔍 Liaw Jeffrey (Executive)

Company: COPART INC (CPRT)

Report Date: 2026-04-15

Detailed Transactions and Holdings:

• Acquired 4,523 shares of Common Stock at $6.78 per share (Direct)
  Date: 2026-04-15 | Code: M | equity_swap_involved: 0 | shares_owned_after: 60,493.00 | transaction_form_type: 4
• Acquired 43,166 shares of Common Stock at $8.7 per share (Direct)
  Date: 2026-04-15 | Code: M | equity_swap_involved: 0 | shares_owned_after: 103,659.00 | transaction_form_type: 4
• Acquired 809 shares of Common Stock at $6.78 per share (Direct)
  Date: 2026-04-15 | Code: M | equity_swap_involved: 0 | shares_owned_after: 104,468.00 | transaction_form_type: 4
• Acquired 1,277 shares of Common Stock at $8.7 per share (Direct)
  Date: 2026-04-15 | Code: M | equity_swap_involved: 0 | shares_owned_after: 105,745.00 | transaction_form_type: 4
• Sold 23,870 shares of Common Stock at $33.18 per share (Direct)
  Date: 2026-04-15 | Code: S | equity_swap_involved: 0 | shares_owned_after: 81,875.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 2,343 shares of Common Stock at $33.17 per share (Direct)
  Date: 2026-04-15 | Code: S | equity_swap_involved: 0 | shares_owned_after: 79,532.00 | transaction_form_type: 4 | Footnotes: F3, F4
• Sold 4,523 shares of Employee Stock Option (right to buy) at $6.78 per share (Derivative)
  Date: 2026-04-15 | Code: M | Expires: 2026-10-10 | equity_swap_involved: 0 | shares_owned_after: 6,145.00 | transaction_form_type: 4 | Footnotes: F5
• Sold 43,166 shares of Employee Stock Option (right to buy) at $8.7 per share (Derivative)
  Date: 2026-04-15 | Code: M | Expires: 2027-10-04 | equity_swap_involved: 0 | shares_owned_after: 223,505.00 | transaction_form_type: 4 | Footnotes: F6
• Sold 809 shares of Employee Stock Option (right to buy) at $8.7 per share (Derivative)
  Date: 2026-04-15 | Code: M | Expires: 2027-10-04 | equity_swap_involved: 0 | shares_owned_after: 222,696.00 | transaction_form_type: 4 | Footnotes: F6
• Sold 1,277 shares of Employee Stock Option (right to buy) at $6.78 per share (Derivative)
  Date: 2026-04-15 | Code: M | Expires: 2026-10-10 | equity_swap_involved: 0 | shares_owned_after: 4,868.00 | transaction_form_type: 4 | Footnotes: F5

Footnotes:

• F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.97 to $33.46, inclusive. The reporting person undertakes to provide to Copart, Inc., any security holder of Copart, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4.
• F2: The reported sale of 2,343 shares occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 15, 2025.
• F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.99 to $33.45, inclusive. The reporting person undertakes to provide to Copart, Inc., any security holder of Copart, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4.
• F4: The reported sale of 23,870 shares of occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 15, 2025.
• F5: Twenty percent (20%) of the options vested on the first anniversary of the grant date (October 10, 2017) and the balance vested on a monthly basis over the 48 months succeeding such first anniversary.
• F6: Twenty percent (20% ) of the options vested on the first anniversary of the grant date (October 4, 2018) and the balance vested on a monthly basis over the 48 months succeeding such first anniversary.